ShigETEC

ShigETEC vaccine (live attenuated) · Eveliqure Biotechnologies GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ShigETEC, covering 2025-07-08 to 2025-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old [Phase 2]

See pricing